C156H195Cl6F3N20O13 — CID 158602656
1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(2,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3-methoxy-4-methylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-[4-methyl-2-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;2-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-5-methylbenzonitrile;5-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-2-methylbenzonitrile (PubChem CID 158602656) has the molecular formula C156H195Cl6F3N20O13 and a molecular weight of 2828.11 g/mol. Its IUPAC name is 1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(2,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3-methoxy-4-methylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-[4-methyl-2-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;2-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-5-methylbenzonitrile;5-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-2-methylbenzonitrile.
| Compound Name | 1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(2,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3-methoxy-4-methylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-[4-methyl-2-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;2-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-5-methylbenzonitrile;5-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-2-methylbenzonitrile |
|---|---|
| PubChem CID | 158602656 |
| Molecular Formula | C156H195Cl6F3N20O13 |
| Molecular Weight | 2828.11 g/mol |
| Exact Mass | 2823.33 |
| IUPAC Name | 1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(2,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3,4-dimethylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-(3-methoxy-4-methylanilino)cyclohexyl]oxyethanone;1-[4-(4-chlorophenyl)piperazin-1-yl]-2-[4-[4-methyl-2-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;2-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-5-methylbenzonitrile;5-[[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]-2-oxoethoxy]cyclohexyl]amino]-2-methylbenzonitrile |
| SMILES | COc1cc(NC2CCC(OCC(=O)N3CCN(c4ccc(Cl)cc4)CC3)CC2)ccc1C.Cc1ccc(NC2CCC(OCC(=O)N3CCN(c4ccc(Cl)cc4)CC3)CC2)c(C#N)c1.Cc1ccc(NC2CCC(OCC(=O)N3CCN(c4ccc(Cl)cc4)CC3)CC2)c(C(F)(F)F)c1.Cc1ccc(NC2CCC(OCC(=O)N3CCN(c4ccc(Cl)cc4)CC3)CC2)c(C)c1.Cc1ccc(NC2CCC(OCC(=O)N3CCN(c4ccc(Cl)cc4)CC3)CC2)cc1C.Cc1ccc(NC2CCC(OCC(=O)N3CCN(c4ccc(Cl)cc4)CC3)CC2)cc1C#N |
| InChI | InChI=1S/C26H31ClF3N3O2.2C26H31ClN4O2.C26H34ClN3O3.2C26H34ClN3O2/c1-18-2-11-24(23(16-18)26(28,29)30)31-20-5-9-22(10-6-20)35-17-25(34)33-14-12-32(13-15-33)21-7-3-19(27)4-8-21;1-19-2-11-25(20(16-19)17-28)29-22-5-9-24(10-6-22)33-18-26(32)31-14-12-30(13-15-31)23-7-3-21(27)4-8-23;1-19-2-5-23(16-20(19)17-28)29-22-6-10-25(11-7-22)33-18-26(32)31-14-12-30(13-15-31)24-8-3-21(27)4-9-24;1-19-3-6-22(17-25(19)32-2)28-21-7-11-24(12-8-21)33-18-26(31)30-15-13-29(14-16-30)23-9-4-20(27)5-10-23;1-19-3-12-25(20(2)17-19)28-22-6-10-24(11-7-22)32-18-26(31)30-15-13-29(14-16-30)23-8-4-21(27)5-9-23;1-19-3-6-23(17-20(19)2)28-22-7-11-25(12-8-22)32-18-26(31)30-15-13-29(14-16-30)24-9-4-21(27)5-10-24/h2-4,7-8,11,16,20,22,31H,5-6,9-10,12-15,17H2,1H3;2-4,7-8,11,16,22,24,29H,5-6,9-10,12-15,18H2,1H3;2-5,8-9,16,22,25,29H,6-7,10-15,18H2,1H3;3-6,9-10,17,21,24,28H,7-8,11-16,18H2,1-2H3;3-5,8-9,12,17,22,24,28H,6-7,10-11,13-16,18H2,1-2H3;3-6,9-10,17,22,25,28H,7-8,11-16,18H2,1-2H3 |
| InChIKey | HVVGZCWNLIKYMT-UHFFFAOYSA-N |
| XLogP | 29.81 |
| TPSA | 325.67 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 198 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2828.11 |
| LogP ≤ 5 | 29.81 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 27 |